Jun. 29, 2018

Late breaker presentations to be made at the international aids conference 2018


  • First results from PARTNER2 – a follow-up to the landmark PARTNER study – with new evidence on the effectiveness of “treatment as prevention” in gay male couples 
  • Data from theANRS PREVENIR studyof daily and “on demand” PrEP in men who have sex with men
  • New research on the possibility that feminizing hormone therapy may affect the efficacy of PrEP in transgender women
  • Data on prevention and treatment progress in key countries, including results from the Namibia Population-Based HIV Impact Assessment (PHIA) 
  • Results from the SEARCH study of HIV “test-and-treat” using a multi-disease approach and streamlined care in Kenya and Uganda  
  • Study identifying cost-effective strategies that could cut HIV infections and deaths in half in Ukraine 
  • Results from RIVER, the first randomized controlled trial of a “kick and kill” approach to attacking HIV reservoirs 
  • Detailed safety and efficacy data from the GEMINI studies of an experimental two-drug treatment for HIV (dolutegravir + lamivudine) 
  • Safety of Dolutegravir in pregnancy: Late breaking findings, interpretations and implications.